Data, Data, Everywhere, But How Much Of It Makes A Real Difference?
Philips Makes A Case For The Value Approach
Executive Summary
Having a single patient's complete health care information all in one place was a dream that US visionaries began to talk up around a decade ago. The idea was that fast, electronic support for doctors would aid clinical decision making and efficiency. Ten years on, there is still much work to do before the dream is realized, says Philips' Carla Kriwet. But a solution is within reach.
You may also be interested in...
Change Is Coming In Health Care, If Not Yet At The Speeds Of Other Consumer Industries
The advent of COVID-19 and its effects on care delivery have meant that short-term priorities for health care systems have switched temporarily to public health emergency mode. But the longer-term need to restructure delivery around outcomes and federated data management for patients is here to stay, says Royal Philips’ Jeroen Tas.
Leading Medtechs See Organic Growth Across A Market In Flux
In 2018, the top 100 publicly listed and reportable medical device technology companies had global sales spanning from over $30bn to some $100m in the lower reaches. As the latest In Vivo Medtech 100 ranking shows, many of the major changes in value sales were linked to company restructurings. But there were some impressive organic gains too.
Post-Brexit MHRA Will Embrace Medtech ‘Innovation Pull’ In The UK
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Need a specific report? 1000+ reports available
Buy Reports